Golden Age Health (GAH) is thrilled to announce its participation in the highly anticipated JPM Healthcare Conference, set to take place in San Francisco from Jan 8 – 11, 2024.
With a focus on innovative products and solutions and cutting-edge healthcare technologies, GAH aims to contribute significantly to the ongoing dialogue surrounding healthcare transformation. At GAH we strive to redefine patient access to medicine, overcoming existing limitations. Patient access is the company priority, anywhere and at any time.
This conference serves as an invaluable platform for engagement with industry leaders, investors, and stakeholders, fostering collaboration and sharing insights that will help to shape the future of healthcare.
“We are excited to be part of the JPM Healthcare conference and look forward to share with our colleagues our innovative approaches that address the evolving patient needs”, said Michel Vounatsus, Co-founder and Executive Chairman.
Michel Vounatsus, Co-founder and Executive Chairman, Yossi BenAmram, Co-founder and CSO, and Branimir Brankov, Partner and EVP Global BD&L will attend the conference.
For meeting inquiries please contact [email protected] .
GAH LLC:
GAH is a newly established pharmaceutical company with a focus on delivering transformative products and solutions. GAH strives to improve patient access and outcomes and drive positive change in the healthcare ecosystems.
For more information about GAH visit GAH website www.gahbioventures.com